Home
Saba Capital Management reported a 4.95% stake in abrdn Life Sciences Investors HQL · 1,464,161 sh · amendment
Trade details
- Type
- 5% stake report
- Report
- 13D · amendment
- Stake
- 4.95%
- Last report
- 5.7% · filed 26/02/11
- Shares held
- 1,464,161 sh
- Class
- Common Shares, $0.01 par value
- Holder
- Saba Capital Management
- Event date
- 26/02/19
- Filed
- 26/02/23
4.95% stake · below 5%
- Stake
- 4.95%
- Last report
- 5.7%
- Since last report
- −0.8pp
abrdn Life Sciences Investors trades, last 26 weeks
What else happened in abrdn Life Sciences Investors around then
Filed or reported within 30 days of the trade day · 01/20~03/21Saba Capital Management's other 5% stake reports
- Saba Capital Management
5% stakeVirtus Total Return Fund
5% stakeVirtus Total Return Fund
ZTR
5.04% stake
2,519,703 sh
5.04% stake
Filed 09/30
- Saba Capital Management
5% stakeJapan Smaller Capitalization Fund
5% stakeJapan Smaller Capitalization Fund
JOF
8.8% stake
2,494,542 sh
8.8% stake
Filed 09/23
- Saba Capital Management
5% stakeBlackRock ESG Capital Allocation Term Trust
5% stakeBlackRock ESG Capital Allocation Term Trust
ECAT
12.66% stake
12,588,023 sh
12.66% stake
Filed 09/21
- Saba Capital Management
5% stakeBlackRock ESG Capital Allocation Term Trust
5% stakeBlackRock ESG Capital Allocation Term Trust
ECAT
13.67% stake
13,593,042 sh
13.67% stake
Filed 09/02
- Saba Capital Management
5% stakeJapan Smaller Capitalization Fund
5% stakeJapan Smaller Capitalization Fund
JOF
7.73% stake
2,190,551 sh
7.73% stake
Filed 08/31
